A detailed history of Merit Financial Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Merit Financial Group, LLC holds 2,776 shares of VRTX stock, worth $1.39 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,776
Previous 3,777 26.5%
Holding current value
$1.39 Million
Previous $1.77 Million 27.06%
% of portfolio
0.03%
Previous 0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$460.0 - $505.78 $460,460 - $506,285
-1,001 Reduced 26.5%
2,776 $1.29 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $134,341 - $166,051
342 Added 9.96%
3,777 $1.77 Million
Q1 2024

May 06, 2024

BUY
$407.69 - $446.08 $602,158 - $658,860
1,477 Added 75.43%
3,435 $1.44 Million
Q4 2023

Feb 06, 2024

SELL
$343.0 - $410.68 $582,414 - $697,334
-1,698 Reduced 46.44%
1,958 $796,000
Q3 2023

Nov 07, 2023

SELL
$338.18 - $362.46 $92,999 - $99,676
-275 Reduced 7.0%
3,656 $1.27 Million
Q2 2023

Aug 01, 2023

BUY
$314.42 - $351.91 $722,222 - $808,337
2,297 Added 140.58%
3,931 $1.38 Million
Q1 2023

Apr 24, 2023

BUY
$283.23 - $323.1 $462,797 - $527,945
1,634 New
1,634 $514,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.